A. Grimaldi, Médecine-Sciences, Flammarion. 2019. 2. Organisation mondiale de la santé. Rapport mondial sur le diabète : résumé d'orientation, 2016.

S. Fosse-edorh, L. Mandereau-bruno, and C. Piffaretti, Le poids du diabète en France en 2016. Synthèse épidémiologique, vol.8, 2018.

C. Druet, C. Roudier, I. Romon, F. Assogba, and I. Bourdel-marchasson, Échantillon national témoin représentatif des personnes diabétiques, Caractéristiques, état de santé, prise en charge et poids économique des personnes diabétiques, 2007.

P. Pr and . Darmon, À la hausse ou à la baisse HbA1c : attention aux pièges, Quotid Médecin N°9318, 2014.

D. Control and C. Group, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N Engl J Med, vol.329, issue.14, pp.977-986, 1993.

C. C. Barr, Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive insulin therapy, by The Diabetes Control and Complications

, Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N. Engl. J. Med, vol.342, issue.5, pp.459-60, 2000.

T. J. Orchard, D. M. Nathan, B. Zinman, P. Cleary, D. Brillon et al.,

, Association Between 7 Years of Intensive Treatment of Type 1 Diabetes and Long-term Mortality, JAMA. 6 janv, vol.313, issue.1, p.45, 2015.

, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). The Lancet. sept, UK Prospective Diabetes Study (UKPDS) Group, vol.352, pp.837-53, 1998.

R. R. Holman, S. K. Paul, M. A. Bethel, D. R. Matthews, and H. Neil, 10-Year Follow-up of

H. Zhou, Y. Tian, Y. Du, H. Sun, Y. Zhong et al., Effects of intensive glucose lowering in treatment of type 2 diabetes mellitus on cardiovascular outcomes: A metaanalysis of data from 58,160 patients in 13 randomized controlled trials, Int J Cardiol. sept, vol.359, issue.15, pp.50-58, 2008.

M. Lind, A. Pivodic, A. Svensson, A. F. Ólafsdóttir, H. Wedel et al., HbA 1c level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population based cohort study, BMJ. 28 août, 2019.

, Intensive Glucose Lowering in Type 2 Diabetes, N Engl J Med. 12 juin, vol.358, issue.24, pp.2545-59, 2008.

P. Darmon and B. Bauduceau, Prise de position de la Société Francophone du Diabète (SFD) sur la prise en charge médicamenteuse de l'hyperglycémie du patient diabétique de type

, HAS -Diabète de type 1 de l'adulte -Guide affection longue durée -Juillet, Médecine Mal Métaboliques, vol.13, p.22, 2007.

T. Battelino, T. Danne, R. M. Bergenstal, S. A. Amiel, R. Beck et al., Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range, Diabetes Care. août, vol.42, issue.8, pp.1593-603, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02749292

R. W. Beck, R. M. Bergenstal, T. D. Riddlesworth, C. Kollman, Z. Li et al.,

, Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials, HAS 2014 -Actes et prestations Affection de Longue Durée -Diabète de type 1, vol.42, pp.400-405, 2019.

. Synthèse, Guide parcours de soins Diabète de type 2 de l'adulte

D. Sur,

, Lamouroux A, Magnan A, Vervloet D. Compliance, observance ou adhésion thérapeutique : de quoi parlons-nous ?, COUF 2017 -Rétinopathie Diabétique, vol.22, pp.31-35, 2005.

E. Sabaté, World Health Organization, éditeurs. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization, vol.198, 2003.

A. J. Karter, A. Ferrara, J. A. Darbinian, L. M. Ackerson, and J. V. Selby, Self-monitoring of blood glucose: language and financial barriers in a managed care population with diabetes, Diabetes Care. 1 avr, vol.23, issue.4, pp.477-83, 2000.

P. Lecomte, I. Romon, S. Fosse, D. Simon, and A. Fagot-campagna, Self-monitoring of blood glucose in people with type 1 and type 2 diabetes living in France: The Entred study, Diabetes Metab. juin, pp.219-245, 2001.

J. C. Pickup, S. C. Freeman, and A. J. Sutton, Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: metaanalysis of randomised controlled trials using individual patient data, BMJ. 7 juill, vol.343, pp.3805-3805, 2011.

N. Poolsup, N. Suksomboon, and A. Kyaw, Systematic review and meta-analysis of the effectiveness of continuous glucose monitoring (CGM) on glucose control in diabetes, Diabetol Metab Syndr, vol.5, issue.1, p.39, 2013.

R. N. Janapala, J. S. Jayaraj, N. Fathima, T. Kashif, N. Usman et al., Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Type 2 Diabetes Mellitus: A Systematic Review with Meta-analysis, Cureus. 12 sept, 2019.

M. Lind, W. Polonsky, I. B. Hirsch, T. Heise, J. Bolinder et al., Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1

, Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial, JAMA. 24 janv, vol.317, issue.4, pp.379-87, 2017.

R. W. Beck, T. Riddlesworth, K. Ruedy, A. Ahmann, R. Bergenstal et al., Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial, JAMA. 24 janv, vol.317, issue.4, pp.371-379, 2017.

I. Krass, P. Schieback, and T. Dhippayom, Adherence to diabetes medication: a systematic review, Diabet Med. juin, vol.32, issue.6, pp.725-762, 2015.

M. Tiv, J. Viel, F. Mauny, E. Eschwège, A. Weill et al., Medication Adherence in Type 2 Diabetes: The ENTRED Study, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00823393

G. Malaga, PLoS ONE. 5 mars, vol.7, issue.3, p.32412, 2012.

J. A. Cramer, A Systematic Review of Adherence With Medications for Diabetes

, Diabetes Care. 1 mai, vol.27, issue.5, pp.1218-1242, 2004.

A. Mcgovern, Z. Tippu, W. Hinton, N. Munro, M. Whyte et al., Comparison of medication adherence and persistence in type 2 diabetes: A systematic review and metaanalysis, Diabetes Obes Metab. avr, vol.20, issue.4, pp.1040-1043, 2018.

M. Tiv, J. Viel, F. Mauny, E. Eschwège, A. Weill et al., Observance thérapeutique des patients diabétiques de type 1, étude Entred, Diabetes Metab. mars, vol.36, p.20, 2007.

R. J. Anderson, K. E. Freedland, R. E. Clouse, and P. J. Lustman, The Prevalence of Comorbid Depression in Adults With Diabetes: A meta-analysis, Diabetes Care. 1 juin, vol.24, issue.6, pp.1069-78, 2001.

N. C. Foster, R. W. Beck, K. M. Miller, M. A. Clements, M. R. Rickels et al., State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in, 2016.

, Diabetes Technol Ther. févr, vol.21, issue.2, pp.66-72, 2019.

S. Clavel, B. Guerci, H. Hanaire, V. Lassmann-vague, R. Leroy et al., Quand et comment traiter un patient diabétique par pompe à insuline externe ?, Médecine Mal Métaboliques. mars, vol.3, issue.2, pp.219-246, 2009.

D. Sur,

B. Karges, A. Schwandt, B. Heidtmann, O. Kordonouri, E. Binder et al.,

, Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes, vol.318, pp.1358-66, 2017.

M. L. Misso, K. J. Egberts, M. Page, D. O'connor, and J. Shaw, Continuous subcutaneous insulin

J. C. Pickup and A. J. Sutton, Severe hypoglycaemia and glycaemic control in Type 1 diabetes

R. A. Vigersky, S. Huang, T. L. Cordero, J. Shin, S. W. Lee et al.,

. Hba1c, total daily insuline dose, and treatment satisfaction with insulin pump therapy compared to multiple daily insulin injections in patients with type 2 diabetes irrespective of baselin C-peptide levels, Endocr Pract. mai, vol.24, issue.5, pp.446-52, 2018.

Y. Reznik, O. Cohen, R. Aronson, I. Conget, S. Runzis et al., Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial. The Lancet, vol.384, pp.1265-72, 2014.

Y. Reznik, D. Endocrinology, and . Department,

J. M. France, D. Endocrinology, and . Department, The OPT2MISE Study -A Review of the Major Findings and Clinical Implications

, Eur Endocrinol, vol.11, issue.2, p.70, 2015.

Y. Reznik, J. Morera, A. Rod, C. Coffin, E. Rousseau et al.,

, Infirmier en pratique avancée un nouveau statut de professionnel de santé -Ordre National des Infirmiers -19072018, Continuous Subcutaneous Insulin Infusion in Type 2 Diabetes Mellitus: A Survey on a Cohort of 102 Patients with Prolonged Follow-Up, vol.12, pp.931-937, 2010.

D. B. Rubin, Multiple Imputation for Nonresponse in Surveys, 2004.

Y. Bourgueil, P. L. Fur, J. Mousquès, and E. Yilmaz, La coopération entre médecins généralistes et infirmières pour le suivi des patients diabétiques de type 2 Evaluation médicoéconomique de l'expérimentation ASALEE, p.149

J. Lawler, P. Trevatt, C. Elliot, and A. Leary, Does the Diabetes Specialist Nursing workforce impact the experiences and outcomes of people with diabetes? A hermeneutic review of the evidence, Hum Resour Health. déc, vol.17, issue.1, p.65, 2019.

F. Riordan, S. M. Mchugh, K. Murphy, J. Barrett, and P. M. Kearney, The role of nurse specialists in the delivery of integrated diabetes care: a cross-sectional survey of diabetes nurse specialist services, BMJ Open. août, vol.7, issue.8, p.15049, 2017.

, Résultats de l'étude : Qualité de vie avec le diabète

L. Diabète, , 2018.

A. Nouwen, K. Winkley, J. Twisk, C. E. Lloyd, M. Peyrot et al., Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis

, Diabetologia. 1 déc, vol.53, issue.12, pp.2480-2486, 2010.

E. Shuttlewood, D. Zoysa, N. Rankin, D. Amiel, and S. , A qualitative evaluation of DAFNE-HART: A psychoeducational programme to restore hypoglycaemia awareness, Diabetes Res Clin Pract. août, vol.109, issue.2, pp.347-54, 2015.

F. J. Snoek, N. Van-der-ven, C. Lubach, M. Chatrou, H. J. Adèr et al.,

, Effects of cognitive behavioural group training (CBGT) in adult patients with poorly controlled insulin-dependent (type 1) diabetes: a pilot study, Patient Educ Couns, vol.45, issue.2, pp.143-151, 2001.

J. A. Fosbury, C. M. Bosley, A. Ryle, P. H. Sönksen, and S. L. Judd, A trial of cognitive analytic therapy in poorly controlled type I patients. Diabetes Care, vol.20, pp.959-64, 1997.

F. J. Snoek, N. Ven, and R. J. Heine, Improving Glycemic Control and Well-being: A

, Cognitive Behavioral Based Group Training for Poorly Controlled Type 1 Diabetes Patients, Diabetes. 1 mai, vol.48, issue.5, pp.9-9, 1999.

X. Serment,